Trial intelligence / Profile preview

Randomised Phase II Study of Dabigatran Etexilate Dosing in Patients With Mechanical Heart Valves

2010-022685-27Phase 2Terminated

Sponsor
Boehringer Ingelheim
Start
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of dabigatran in Mechanical valve replacement (2 arms), sponsored by Boehringer Ingelheim. Started Jul 2011; status: terminated.

02

Drugs

dabigatran
03

Conditions

Mechanical valve replacement

Beyond the preview

Go deeper on 2010-022685-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022685-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call